BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33020483)

  • 1. Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency.
    Werner-Klein M; Grujovic A; Irlbeck C; Obradović M; Hoffmann M; Koerkel-Qu H; Lu X; Treitschke S; Köstler C; Botteron C; Weidele K; Werno C; Polzer B; Kirsch S; Gužvić M; Warfsmann J; Honarnejad K; Czyz Z; Feliciello G; Blochberger I; Grunewald S; Schneider E; Haunschild G; Patwary N; Guetter S; Huber S; Rack B; Harbeck N; Buchholz S; Rümmele P; Heine N; Rose-John S; Klein CA
    Nat Commun; 2020 Oct; 11(1):4977. PubMed ID: 33020483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and regulation of interleukin 6 and its receptor at the maternal-conceptus interface during pregnancy in pigs.
    Yoo I; Han J; Kim M; Jang H; Sa S; Choi SH; Ka H
    Theriogenology; 2017 Jul; 96():85-91. PubMed ID: 28532843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.
    Chatterjee M; Hönemann D; Lentzsch S; Bommert K; Sers C; Herrmann P; Mathas S; Dörken B; Bargou RC
    Blood; 2002 Nov; 100(9):3311-8. PubMed ID: 12384432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
    Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
    Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Interleukin 6 signaling receptors in carotid atherosclerosis.
    Ziegler L; Lundqvist J; Dreij K; Wallén H; de Faire U; Paulsson-Berne G; Hedin U; Matic L; Gigante B
    Vasc Med; 2021 Feb; 26(1):3-10. PubMed ID: 33350884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing.
    Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung.
    Jing B; Wang T; Sun B; Xu J; Xu D; Liao Y; Song H; Guo W; Li K; Hu M; Zhang S; Ling J; Kuang Y; Zhang T; Zhou BP; Yao F; Deng J
    Cancer Res; 2020 Feb; 80(4):784-797. PubMed ID: 31848193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid monocyte infiltration following retinal detachment is dependent on non-canonical IL6 signaling through gp130.
    Wang X; Miller EB; Goswami M; Zhang P; Ronning KE; Karlen SJ; Zawadzki RJ; Pugh EN; Burns ME
    J Neuroinflammation; 2017 Jun; 14(1):121. PubMed ID: 28645275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling.
    Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A
    Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic Acid and IL-6 Trans-signaling Interact via YAP/TAZ and STAT3 Signaling Pathways in Human Trabecular Meshwork Cells.
    Yemanyi F; Raghunathan V
    Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):29. PubMed ID: 33216119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.
    Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL
    Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells.
    Yang L; Han S; Sun Y
    Biochem Biophys Res Commun; 2014 Oct; 453(3):582-7. PubMed ID: 25285632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression.
    Cui D; Huang Z; Liu Y; Ouyang G
    Cell Mol Life Sci; 2017 Dec; 74(23):4287-4291. PubMed ID: 28884337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of cilia-localized Il-6R alpha by 17beta-estradiol in mouse and human fallopian tubes.
    Shao R; Nutu M; Karlsson-Lindahl L; Benrick A; Weijdegård B; Lager S; Egecioglu E; Fernandez-Rodriguez J; Gemzell-Danielsson K; Ohlsson C; Jansson JO; Billig H
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C140-51. PubMed ID: 19420002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
    Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
    Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
    Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
    Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer.
    Sansone P; Ceccarelli C; Berishaj M; Chang Q; Rajasekhar VK; Perna F; Bowman RL; Vidone M; Daly L; Nnoli J; Santini D; Taffurelli M; Shih NN; Feldman M; Mao JJ; Colameco C; Chen J; DeMichele A; Fabbri N; Healey JH; Cricca M; Gasparre G; Lyden D; Bonafé M; Bromberg J
    Nat Commun; 2016 Feb; 7():10442. PubMed ID: 26858125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.
    Sansone P; Berishaj M; Rajasekhar VK; Ceccarelli C; Chang Q; Strillacci A; Savini C; Shapiro L; Bowman RL; Mastroleo C; De Carolis S; Daly L; Benito-Martin A; Perna F; Fabbri N; Healey JH; Spisni E; Cricca M; Lyden D; Bonafé M; Bromberg J
    Cancer Res; 2017 Apr; 77(8):1927-1941. PubMed ID: 28202520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 controls recycling and degradation, but not internalization of its receptors.
    Flynn CM; Kespohl B; Daunke T; Garbers Y; Düsterhöft S; Rose-John S; Haybaeck J; Lokau J; Aparicio-Siegmund S; Garbers C
    J Biol Chem; 2021; 296():100434. PubMed ID: 33610555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.